Target intelligence / Profile preview

NUDT19 divergent transcript (NUDT19-DT)

Target
NUDT19-DT
Molecular classification
Other (Non-coding RNA, divergent transcript)
01

Overview

NUDT19 divergent transcript (NUDT19-DT) refers to a non-coding RNA gene, annotated as an RNA gene associated with the NUDT19 locus. Unlike NUDT19 (Nudix hydrolase 19), which is a protein-coding gene and a known metabolic enzyme, NUDT19-DT is not characterized as an enzyme, receptor, transporter, or otherwise typical therapeutic target. Evidence does not support a functional protein product or therapeutic relevance for NUDT19-DT; it may function in gene regulation or simply represent transcriptional noise. No known drugs, molecular mechanisms, disease associations, or biomarker uses have been described for NUDT19-DT in the scientific literature or major biomedical databases. NUDT19-DT is not recognized as a druggable target, nor as a receptor, enzyme, transporter, or similar molecular entity relevant to drug development and pharmacology. All known biomedical relevance and druggability pertains to NUDT19, not its divergent transcript.

Other names
NUDT19-DT

Beyond the preview

Go deeper on NUDT19 divergent transcript (NUDT19-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NUDT19 divergent transcript (NUDT19-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call